Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022;24(4):E319-325. doi:
10.1001/amajethics.2022.319.
Zahra H. Khan, MS, Yoshiko Iwai, MS, and Sayantani DasGupta, MD, MPH
In 2020, the authors of this article published “Abolition Medicine” as one contribution to international abolitionist conversations responding to widespread anti-Black police violence and inequity laid bare by the COVID-19 pandemic.
AMA J Ethics. 2022;24(3):E239-246. doi:
10.1001/amajethics.2022.239.
On this episode of Ethics Talk, Zahra H. Khan, Yoshiko Iwai, and Dr Sayantani DasGupta outline how “abolition medicine” can motivate critical responses to medicine’s expressions of hyper-punitive, deeply racialized exercises of state authority.
Dr Stephen P. Richmond joins Ethics Talk to discuss his article, coauthored with Dr Vanessa Grubbs: “How Abolition of Race-Based Medicine Is Necessary to American Health Justice.”
There are fewer Black men in US medical schools today than in 1970, although their contributions are key to building medicine’s capacity to equitably promote healing.
AMA J Ethics. 2021;23(12):E919-925. doi:
10.1001/amajethics.2021.919.